QIAGEN N.V.: QIAGEN showcases latest technologies to advance cancer research at AACR Annual Meeting 2023
Venlo, the Netherlands, April 14, 2023 (GLOBE NEWSWIRE) -- QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the launch of QIAseq Targeted cfDNA Ultra Panels that will enable researchers
Source: finanznachrichten.de